Hepatocellular Expression of SIRT1 and Its Effect on Hepatocellular Carcinoma Progression: A Future Therapeutic Perspective
Hepatocellular carcinoma (HCC) is an aggressive primary hepatic malignancy with a significant morbidity and mortality rate. Although chemotherapy along with surgical incision is believed to be an effective therapeutic approach, to date recurrence is being lifted a major concern. Thus, identifying an...
Saved in:
| Main Authors: | Meseret Derbew Molla, Gashaw Dessie, Yonas Akalu, Birhanu Ayelign |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | International Journal of Hepatology |
| Online Access: | http://dx.doi.org/10.1155/2020/2374615 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Physiological Effect of Ghrelin on Body Systems
by: Yonas Akalu, et al.
Published: (2020-01-01) -
Future perspectives on immunotherapy for hepatocellular carcinoma
by: Landon L. Chan, et al.
Published: (2025-03-01) -
SIRT3 functions as a tumor suppressor in hepatocellular carcinoma
by: Xianchun Zeng, et al.
Published: (2017-03-01) -
Systemic treatments for hepatocellular carcinoma: challenges and future perspectives
by: Francesco Tovoli, et al.
Published: (2018-01-01) -
Responsive biomaterials for therapeutic strategies of hepatocellular carcinoma
by: Xun Liao, et al.
Published: (2025-08-01)